Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Mannatech	True Drinks	FSD Pharma	Happiness Biotech Group	Glucose Health
Symbol	NASDAQ:MTEX	OTCMKTS:TRUU	NASDAQ:HUGE	NASDAQ:HAPP	OTCMKTS:GLUC
Price Information
Current Price	$20.04	$0.01	$1.61	$1.70	$2.99
52 Week Range	N/A	N/A	Buy	N/A	N/A
MarketRank™
Overall Score	1.3	0.7	0.3	0.6	0.0
Analysis Score	0.0	0.0	0.0	0.0	0.0
Community Score	2.5	2.2	0.0	2.4	0.0
Dividend Score	0.8	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.0	0.0	0.0	0.0
Earnings & Valuation Score	1.3	1.3	1.3	0.6	0.0
Analyst Ratings
Consensus Recommendation	N/A	N/A	Buy	N/A	N/A
Consensus Price Target	N/A	N/A	$11.00	N/A	N/A
% Upside from Price Target	N/A	N/A	583.23% upside	N/A	N/A
Trade Information
Market Cap	$41.46 million	$31.33 million	$30.85 million	$44.03 million	$34.77 million
Beta	1.09	10.9	1.39	0.6	3.54
Average Volume	4,142	1,007,708	3,475,084	1,013,416	70,440
Sales & Book Value
Annual Revenue	$157.73 million	$1.95 million	$190,000.00	$65.06 million	$290,000.00
Price / Sales	0.26	16.07	162.37	0.68	119.89
Cashflow	$2.49 per share	N/A	N/A	$0.42 per share	N/A
Price / Cash	8.05	N/A	N/A	4.07	N/A
Book Value	$11.43 per share	($0.03) per share	$5.15 per share	$3.18 per share	N/A
Price / Book	1.75	-0.21	0.31	0.53	∞
Profitability
Net Income	$3.29 million	$-3,880,000.00	$-39,200,000.00	$12.69 million	$-250,000.00
EPS	N/A	N/A	($5.55)	N/A	N/A
Trailing P/E Ratio	6.17	1.10	N/A	0.00	0.00
Forward P/E Ratio	∞	∞	N/A	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	5.04%	-255.80%	N/A	N/A	-136.46%
Return on Equity (ROE)	28.69%	N/A	-111.76%	N/A	N/A
Return on Assets (ROA)	11.99%	-165.86%	-92.92%	N/A	-199.60%
Dividend
Annual Payout	$0.64	N/A	N/A	N/A	N/A
Dividend Yield	3.19%	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	14.00%	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	1 Years	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.01%	N/A	N/A	N/A	N/A
Current Ratio	1.40%	0.01%	2.62%	N/A	N/A
Quick Ratio	0.94%	N/A	2.62%	N/A	N/A
Ownership Information
Institutional Ownership Percentage	14.97%	N/A	0.73%	1.57%	N/A
Insider Ownership Percentage	45.80%	18.18%	N/A	N/A	N/A
Miscellaneous
Employees	214	1	9	151	N/A
Shares Outstanding	2.07 million	4.97 billion	19.16 million	25.90 million	11.63 million
Next Earnings Date	5/11/2021 (Estimated)	N/A	5/21/2021 (Estimated)	N/A	5/12/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Optionable	Not Optionable	Not Optionable

Source	Headline
	Glucose Sensor Market Analysis and In-depth study on Market Size Trends, Emerging Growth Factors and Regional Forecast to 2026 \| FMI pharmiweb.com - April 22 at 2:34 PM
	Anti-aging compound improves muscle glucose metabolism in people medicalxpress.com - April 22 at 2:34 PM
	Point-of-Care Glucose Testing Market High trend Opportunities offers Future Business Growth by 2027 openpr.com - April 22 at 9:28 AM
	Fat Mass Accretion From Birth to 5 Years and Metabolic Homeostasis in Childhood: The Healthy Start Study medpagetoday.com - April 21 at 6:08 PM
	Resistance exercise training improves glucose homeostasis by enhancing insulin secretion in C57BL/6 mice nature.com - April 21 at 8:06 AM
	Glucose Health, Inc. Reports March Revenue Triples at Amazon and Announces Major Expansion of TV-Digital Advertising Strategy finance.yahoo.com - April 21 at 8:06 AM
	Ask the Doctors: Fresh fruits and veggies greatly improve health santamariatimes.com - April 20 at 5:39 PM
	Cross-sectional investigation of insulin resistance in youths with autism spectrum disorder. Any role for reduced brain glucose metabolism? nature.com - April 20 at 5:39 PM
	Non-invasive glucose monitoring technology by GlucoModicum, a University of Helsinki spinout miragenews.com - April 20 at 7:38 AM
	GlucoModicum’s non-invasive glucose monitoring technology performs 13x better than previous needle-free approaches uk.finance.yahoo.com - April 20 at 7:38 AM
	Making Health and Wellness a Lifelong Journey outerbanksvoice.com - April 18 at 6:12 PM
	Healthy diet, physical activity promote liver health, says specialist thehindu.com - April 18 at 6:12 PM
	Researchers Identify Clinical Factors That Predict Response to Glucose-Lowering Therapies ajmc.com - April 17 at 7:47 PM
	EXTENSION NEWS: The Healthy Diabetes Plate weatherforddemocrat.com - April 17 at 9:46 AM
	Glucose Health, Inc. (OTCMKTS:GLUC) Sees Large Decline in Short Interest americanbankingnews.com - April 17 at 1:50 AM
	Continuous Glucose Monitoring Device Market Research Report by Component, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19 ca.finance.yahoo.com - April 16 at 8:29 AM
	Dayton LGBT leaders, health officials address vaccine hesitancy in LGBT community wdtn.com - April 16 at 12:22 AM
	HEALTH CHECK: Beware of social media posts promoting rooibos tea as a ‘cure-all’ ewn.co.za - April 15 at 2:21 PM
	Comparison of the acute metabolic effect of different infant formulas and human milk in healthy adults: a randomized trial nature.com - April 15 at 2:21 PM
	Glucose monitors revolutionized diabetes care. Now digital health startups want to bring them to the masses statnews.com - April 15 at 9:20 AM
	PET PEEVES: FreeStyle Libre lets pet owners check glucose levels in diabetic dogs, cats msn.com - April 14 at 7:52 PM
	MAO to offer free health screenings, HIV tests at Montgomery drive-thru health clinic montgomeryadvertiser.com - April 14 at 2:51 PM
	Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial nature.com - April 14 at 9:51 AM
	How to eat healthy, lower blood sugar and feel full, according to science msn.com - April 14 at 9:51 AM
	Hungry all the time? Here's what experts say about your health zeenews.india.com - April 13 at 11:49 PM

Date	Company	Brokerage	Action
8/20/2020	FSD Pharma	Brookline Capital Management	Initiated Coverage
12/6/2019	Happiness Biotech Group	Aegis	Initiated Coverage

(Data available from 4/23/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources